Equip Rotavirus
Active substance
ATC code
Species
Horses (pregnant mares)
Indications
For vaccination of pregnant mares to provide passive transfer of antibodies to foals to reduce the risk of diarrhoea caused by equine rotavirus G3 P12 serotypes.
Mares are able to transfer the passive immunity to the foals 4 weeks after the third vaccination. Foals of the vaccinated mares show an increase in antibodies against equine rotavirus for approximately sixty days.
Dose to be administered and administration route
1.0 ml dose per mare to be administered by deep intramuscular injection.
Vaccination schedule
Pregnant mares should be given three doses of vaccine consisting of a single 1 ml dose administered at the 8th, 9th and 10th month of each pregnancy.
Adverse reactions
In mares a transient increase (up to 1.8 °C) in rectal temperature which may last up to 2 days following vaccination may be very commonly observed.
A small visible soft to firm swelling (2.5 ≤ x ≤ 3.5 cm) lasting generally for only two days may be commonly observed. The swelling may be painful for 1—2 days. In most cases these small and transient injection site reactions resolve with no need for treatment.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
- common (more than 1 but less than 10 animals in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals)
- rare (more than 1 but less than 10 animals in 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated reports).
